Hao Feng Medical Honored as 'Pioneer in Sci-Tech Innovation' and Files IPO Prospectus

Haofeng Medical Honored with "2024 Lingang Lanwan Science and Technology Pioneer Enterprise" Award!

This honor is an affirmation of Haofeng Medical's scientific and technological innovation achievements over the past year.

In the future, Haofeng Medical will continue to focus on the upstream CDMO industry of medical devices, constantly enhancing its technical capabilities and market competitiveness.

In the field of interventional medical device production equipment, we will promote the application of cutting-edge technologies, provide more efficient and intelligent products, and help customers optimize production processes, reduce costs, and enhance economic benefits.

In the field of general consumables processing, we will continuously enhance our capabilities in material research and development, product design, and process innovation to meet customers' diverse production needs and promote more high-quality, high-performance products to enter the market.

We sincerely invite you to join hands and work together to promote the development of global health事业.

Shanghai Hao Feng Medical Technology Co., Ltd. was founded in 2013, with subsidiaries including Medcore Medical Technology (Shanghai) Co., Ltd. and Shenzhen Chongzhan Medical Equipment Co., Ltd. The group's headquarters is located in the Life Blue Bay area of the Lingang New District in Shanghai, with research, development, and production bases established in Shenzhen and Qidong. The company owns three major industrial platforms: equipment platform, component platform, and energy platform. With over 200 employees, it has a technical and management team with an average of ten years of experience in the industry. As a leading CDMO platform company for Class III interventional medical devices in China, Haofeng Medical is committed to serving global interventional medical device manufacturers by providing comprehensive services from product development and pre-registration manufacturing to post-market contract production.